Liu Bo, Lin Yihui, Darwanto Agus, Song Xuehui, Xu Guoliang, Zhang Kangling
State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
J Biol Chem. 2009 Nov 20;284(47):32288-95. doi: 10.1074/jbc.M109.045856. Epub 2009 Oct 3.
Propionylation has been identified recently as a new type of protein post-translational modification. Bacterial propionyl-CoA synthetase and human histone H4 are propionylated at specific lysine residues that have been known previously to be acetylated. However, other proteins subject to this modification remain to be identified, and the modifying enzymes involved need to be characterized. In this work, we report the discovery of histone H3 propionylation in mammalian cells. Propionylation at H3 lysine Lys(23) was detected in the leukemia cell line U937 by mass spectrometry and Western analysis using a specific antibody. In this cell line, the propionylated form of Lys(23) accounted for 7%, a level at least 6-fold higher than in other leukemia cell lines (HL-60 and THP-1) or non-leukemia cell lines (HeLa and IMR-90). The propionylation level in U937 cells decreased remarkably during monocytic differentiation, indicating that this modification is dynamically regulated. Moreover, in vitro assays demonstrated that histone acetyltransferase p300 can catalyze H3 Lys(23) propionylation, whereas histone deacetylase Sir2 can remove this modification in the presence of NAD(+). These results suggest that histone propionylation might be generated by the same set of enzymes as for histone acetylation and that selection of donor molecules (propionyl-CoA versus acetyl-CoA) may determine the difference of modifications. Because like acetyl-CoA, propionyl-CoA is an important intermediate in biosynthesis and energy production, histone H3 Lys(23) propionylation may provide a novel epigenetic regulatory mark for cell metabolism.
丙酰化最近被确认为一种新型的蛋白质翻译后修饰。细菌丙酰辅酶A合成酶和人类组蛋白H4在特定赖氨酸残基上发生丙酰化,这些残基此前已知会发生乙酰化。然而,其他发生这种修饰的蛋白质仍有待鉴定,且所涉及的修饰酶也需要进行表征。在这项研究中,我们报告了在哺乳动物细胞中发现组蛋白H3丙酰化。通过质谱分析以及使用特异性抗体的蛋白质免疫印迹分析,在白血病细胞系U937中检测到了H3赖氨酸Lys(23)的丙酰化。在该细胞系中,Lys(23)的丙酰化形式占7%,这一水平比其他白血病细胞系(HL-60和THP-1)或非白血病细胞系(HeLa和IMR-90)至少高6倍。U937细胞中的丙酰化水平在单核细胞分化过程中显著降低,表明这种修饰是动态调控的。此外,体外实验表明,组蛋白乙酰转移酶p300可以催化H3 Lys(23)的丙酰化,而组蛋白去乙酰化酶Sir2在有NAD(+)存在的情况下可以去除这种修饰。这些结果表明,组蛋白丙酰化可能由与组蛋白乙酰化相同的一组酶产生,并且供体分子(丙酰辅酶A与乙酰辅酶A)的选择可能决定修饰的差异。由于与乙酰辅酶A一样,丙酰辅酶A是生物合成和能量产生中的重要中间体,组蛋白H3 Lys(23)丙酰化可能为细胞代谢提供一种新的表观遗传调控标记。